Md Quamrul Hassan
Overview
Explore the profile of Md Quamrul Hassan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akhtar M, Hassan M, Siddiqui A, Alavudeen S, Afzal O, Altamimi A, et al.
Acta Cardiol
. 2022 Oct;
78(2):170-187.
PMID: 36222590
Inotropic agents are generally recommended to use in patients with acute decompensated heart failure (HF) with reduced ejection fraction (HFrEF) concurrent to end-organ dysfunction. However, due to certain pharmacological limitations...
2.
Afzal O, Altamimi A, Shahroz M, Sharma H, Riadi Y, Hassan M
Molecules
. 2021 Apr;
26(8).
PMID: 33924091
Ten benzoxazole clubbed 2-pyrrolidinones (-) as human monoacylglycerol lipase inhibitors were designed on the criteria fulfilling the structural requirements and on the basis of previously reported inhibitors. The designed, synthesized,...
3.
Altamimi A, Bawa S, Athar F, Hassan M, Riadi Y, Afzal O
Chem Biol Drug Des
. 2020 Jun;
96(6):1418-1432.
PMID: 32575154
Eighteen pyrrolidin-2-one linked benzothiazole, and benzimidazole derivatives (10-27) were designed and synthesized. The structure of the compounds was confirmed by elemental and spectral (IR, H-NMR and MS) data analysis. All...
4.
Hassan M, Akhtar M, Afzal O, Hussain I, Akhtar M, Haque S, et al.
Clin Exp Hypertens
. 2019 Oct;
42(5):381-392.
PMID: 31630586
Doxorubicin (DOX) is a potential chemotherapeutic agent but its use is restricted due to cardiotoxicity. Edaravone is a potent-free radical scavenging agent used in cerebral ischaemia. Benidipine is a triple...
5.
Iqbal R, Akhtar M, Hassan M, Jairajpuri Z, Akhtar M, Najmi A
Clin Exp Hypertens
. 2018 Sep;
41(5):434-443.
PMID: 30192645
Pitavastatin inhibits 3 hydroxy 3 methyl glutaryl coenzyme A (HMGCoA) reductase enzyme, preventing cholesterol synthesis along with elevating high density apolipoprotein A1 (Apo-A1). The present study was designed to evaluate...
6.
Shah S, Akhtar M, Hassan M, Akhtar M, Paudel Y, Najmi A
Life Sci
. 2018 Aug;
210:29-39.
PMID: 30107170
Aim: Epidermal growth factor receptor (EGFR) related reactive oxygen species (ROS) generation results in myocardial damage. We aimed to investigate the role of gefitinib (EGFR-tyrosine kinase inhibitor) in diabetic cardiomyopathy...
7.
Imran M, Hassan M, Akhtar M, Rahman O, Akhtar M, Najmi A
Clin Exp Hypertens
. 2018 Mar;
41(1):62-69.
PMID: 29595329
Background: Sacubitril (SAC), a neprilysin inhibitor prevent degradation of neprilysin and activate cGMP signaling pathways leading to rise in blood volume concurrent to blood pressure by means of vasoactive peptides,...
8.
Akhtar M, Khan A, Ali Z, Dewangan R, Rafi M, Hassan M, et al.
Bioorg Chem
. 2018 Mar;
78:158-169.
PMID: 29571113
A new series of benzimidazole linked pyrazole derivatives were synthesized by cyclocondensation reaction through one-pot multicomponent reaction in absolute ethanol. All the synthesized compounds were tested for their in vitro...
9.
Naim M, Alam O, Alam M, Hassan M, Siddiqui N, Naidu V, et al.
Bioorg Chem
. 2017 Nov;
76:98-112.
PMID: 29169079
We herein report the design, synthesis and molecular docking studies of 2,4-thiazolidinedione derivatives containing benzene sulphonyl group which are docked against the Peroxisome Proliferator Activated Receptor (PPARγ) target. Compound 7p...
10.
Khan V, Hassan M, Akhtar M, Najmi A
Drug Res (Stuttg)
. 2017 Oct;
68(3):139-145.
PMID: 28977812
Objective: Cardioprotective potential of aliskiren against isoproterenol-induced myocardial infarction was evaluated in this study. Methods: Wistar albino rats (n=36) were randomly divided into six groups. Normal control rats received 1 ...